Adrenomyeloneuropathy News and Research

RSS
Minoryx Therapeutics initiates phase 1 clinical trial of MIN-102

Minoryx Therapeutics initiates phase 1 clinical trial of MIN-102

Neuropharmacology to publish Nutra Pharma's Alpha-Cobratoxin mechanism study on chronic pain

Neuropharmacology to publish Nutra Pharma's Alpha-Cobratoxin mechanism study on chronic pain

Nutra Pharma's Cobroxin pain reliever now available at CVS stores

Nutra Pharma's Cobroxin pain reliever now available at CVS stores

Sales of Nutra Pharma's Cobroxin totaled $583,955 for fourth-quarter ending December 31, 2009

Sales of Nutra Pharma's Cobroxin totaled $583,955 for fourth-quarter ending December 31, 2009

Nutra Pharma to market its OTC pain reliever in Brazil and Colombia, begins the drug registration process

Nutra Pharma to market its OTC pain reliever in Brazil and Colombia, begins the drug registration process

Cohen Independent Research Group publishes a report profiling Nutra Pharma

Cohen Independent Research Group publishes a report profiling Nutra Pharma

Cobroxin OTC pain reliever is now available online

Cobroxin OTC pain reliever is now available online

Nutra Pharma to launch prescription analgesic for severe chronic pain treatment

Nutra Pharma to launch prescription analgesic for severe chronic pain treatment

Nutra Pharma manufactures first commercial batch of Cobroxin

Nutra Pharma manufactures first commercial batch of Cobroxin

Drug registration process for Nutra Pharma's pain reliever begins

Drug registration process for Nutra Pharma's pain reliever begins

Nutra Pharma’s Cobroxin pain reliever is "Best New Product" at the ECRM Conference

Nutra Pharma’s Cobroxin pain reliever is "Best New Product" at the ECRM Conference

XenaCare Holdings to market Cobroxin pain reliever drug in U.S.

XenaCare Holdings to market Cobroxin pain reliever drug in U.S.

Nutra Pharma submits final packaging and labeling for Cobroxin drug for FDA approval

Nutra Pharma submits final packaging and labeling for Cobroxin drug for FDA approval

Nutra Pharma launches Cobroxin for chronic pain relief

Nutra Pharma launches Cobroxin for chronic pain relief

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.